Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond

Warick, Ruth

doi:10.1001/jama.2022.3026

Cited by 5 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The relatively large number of such outcomes that occur in people with HL (as well as the smaller but still substantial number that are attributable to HL) indicate that action is required in three broad areas: better care for people with HL who experience medical illness, including support for communication as well as management of comorbidity; better treatment and rehabilitation of HL specifically; and more effective public health actions to prevent HL. 47 Our findings support the need for coordinated national strategies for ear and hearing care, 48 with input from a broad range of stakeholders. Such strategies are widely available for conditions such as cancer or mental illness -- but not for ear and hearing care, which is a missed opportunity that must be addressed.…”

Section: Discussionsupporting

confidence: 59%

Associations between hearing loss and clinical outcomes: population-based cohort study

et al. 2023

Self Cite

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 59%

Associations between hearing loss and clinical outcomes: population-based cohort study

et al. 2023

Self Cite

View full text Add to dashboard Cite

“…13 Solutions, and appropriate education, are needed to ensure that individuals with hearing loss (estimated to be 0.6 billion people worldwide) have access to technology that addresses their needs such as headphones, auto-captioning and sign language services to support video consultations. 14 …”

Section: Impact Of the Covid-19 Pandemic And Opportunities Arisingmentioning

confidence: 99%

Remote consultations in primary care across low-, middle- and high-income countries: Implications for policy and care delivery

Williams¹,

Barnard

Collis

et al. 2022

J Health Serv Res Policy

View full text Add to dashboard Cite

The COVID-19 pandemic mandated a substantial switch in primary health care delivery from an in-person to a mainly remote telephone or video service. As the COVID-19 pandemic approaches its third year, limited progress appears to have been made in terms of policy development around consultation methods for the post-acute phase of the pandemic. In September 2020, the International Primary Care Respiratory Group convened a global panel of primary care clinicians – including family physicians, paediatricians, pharmacists, academics and patients – to consider the policy and health management implications of the move to remote consultations in the primary care setting. The group gave special consideration to how and how far remote consultations should be integrated into routine primary health care delivery. Remote consultations can be a useful alternative to in-person consultations in primary care not only in situations where there is a need for viral infection control but also for the routine delivery of chronic disease management. However, they may not be more time efficient for the clinician, and they can add to the workload and work-related stress for primary care practitioners if they remain the dominant consultation mode. Remote consultations are also less appropriate than in-person consultations for new disease diagnosis, dealing with multiple issues and providing complex care. Ensuring health care professionals have the appropriate skill set to effectively deliver remote consultations, administrative and/or IT support and appropriate reimbursement will be key to achieving optimal integration of remote consultations into routine clinical practice. Addressing digital access and digital literacy issues at a societal level will also be essential to ensure individuals have fair and equitable access to the internet and sufficient security for exchange of personal and health-related data.

show abstract

Associations Between Hearing Loss and Health-Related Costs: A Retrospective Population-Based Cohort Study

Tonelli,

Wiebe,

Boulton

et al. 2024

Am J Audiol

View full text Add to dashboard Cite

Purpose: Hearing loss (HL) is a leading cause of disability worldwide, but its health-related costs have been incompletely studied. Our objective was to examine the association between HL and direct health care costs and identify subgroups in which costs associated with HL are especially high. Method: This was a retrospective population-based cohort study of adults treated in a universal health care system between April 2008 and March 2019. HL was identified using administrative health data. We estimate health care costs in 2023 Canadian dollars, including costs for hospitalization, provider claims, ambulatory care visits, prescription medications, and long-term care (LTC). Results: Of 4,424,632 participants, 146,644 (3.3%) had HL. Participants with HL were older ( Mdn = 55 years [interquartile range: 43–68] vs. 35 years [24–50]) and had more comorbidities (1 [0–2] vs. 0 [0–1]) at baseline than participants without, whereas the likelihood of female sex, rural residence, and material deprivation were similar between groups with and without HL. Over median follow-up of 11.0 years, total age–sex adjusted annual health costs and each of its component costs were significantly higher in participants with HL compared to those without (annual total costs: $6,871, 95% confidence interval [CI] [$6,778, $6,962] vs. $4,716, 95% CI [$4,729, $4,763]). After full adjustment (a maximum of 29 comorbidities), annual costs remained significantly higher in participants with HL overall and for certain subcomponents (provider claims, ambulatory visits, and medications), whereas adjusted costs of hospitalization and LTC were lower among people with HL. The magnitude of the incremental costs among participants with HL was most pronounced for younger participants, men, or those with less comorbidity. Total projected annual direct health costs for Alberta residents with HL were $1.01 billion in 2023, of which $125 million (95% CI [$116, $135 million]) was attributable to HL specifically. Conclusions: Compared to those without HL, health costs were markedly higher among participants with HL, partially due to a higher burden of comorbidity. The relatively high population attributable costs of HL suggest that better prevention, recognition, and management of this condition could yield substantial economic benefits. Supplemental Material: https://doi.org/10.23641/asha.27353439

show abstract

Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond

Cited by 5 publications

References 6 publications

Associations between hearing loss and clinical outcomes: population-based cohort study

Associations between hearing loss and clinical outcomes: population-based cohort study

Remote consultations in primary care across low-, middle- and high-income countries: Implications for policy and care delivery

Associations Between Hearing Loss and Health-Related Costs: A Retrospective Population-Based Cohort Study

Contact Info

Product

Resources

About